Comparative Risk of Angioedema With Sacubitril-Valsartan vs Renin-Angiotensin-Aldosterone Inhibitors.

Efe Eworuke,Emily C Welch,Nicole Haug,Casie Horgan, Hye Seung Lee,Yueqin Zhao,Ting-Ying Huang

Journal of the American College of Cardiology（2023）

引用 3|浏览2

暂无评分

摘要

We did not observe an increased risk of angioedema among SV new users compared with ACE inhibitor or ARB users. However, there was an increased risk of angioedema among SV users who recently switched from ACE inhibitor or ARB compared with SV new users.

查看译文

关键词

ACEI,ARB,angioedema,real-world,sacubitril-valsartan

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要